Game-Changing Company Tracker—Google DeepMind Health

Artificial Intelligence Systems in Healthcare—Update

USD 1,500

* Required Fields

USD 1,500

PAY BY INVOICE

Be the first to review this product

Acquired by Google in 2014, DeepMind is leveraging artificial intelligence-based machine learning technology to solve some of the biggest problems in healthcare such as early diagnosis of life-threatening conditions including cancer and diabetes. DeepMind is partnering with NHS at various levels to address healthcare issues. This includes patient data sharing agreements for research on early detection of diabetic retinopathy-induced blindness by analyzing anonymized digital eye scans.

Table of Contents

Game-Changing Company Tracker—Google DeepMind HealthExecutive SummaryKey FindingsGame-Changing Company Tracker ObjectivesArtificial Intelligence Approach to Disease Diagnosis and TreatmentGoogle DeepMind OverviewPotential Impact to MarketLegal DisclaimerThe Frost & Sullivan StoryThe Frost & Sullivan StoryValue Proposition: Future of Your Company & CareerGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 20-Nov-17

Region : North America

Release Date : 07-Nov-17

Region : North America

Release Date : 06-Nov-17

Region : North America

Release Date : 31-Oct-17

Region : North America

Release Date : 31-Oct-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.